Letters to the Editor Nomenclature of Aminoglycoside Resistance Genes: a Comment
In a recent article in your journal, Rather et al. (11) discussed the cloning and characterization of an aminoglycoside resistance determinant that they called the aac(3)-Vb gene. Without meaning to detract from the scientific merits of the paper, we would like to comment on the nomenclature used by the authors to indicate the 3-N-acetylating enzymes and the genes encoding them.
As far as the genetic name is concerned: according to the generally accepted nomenclature proposed by Novick et al. (10) , the proper name for the gene is aacC, not aac (3) .
A more controversial point concerns the isoenzyme classification. What the authors now call the AAC(3)-V or AAC(3)-Va enzyme is identical to the enzyme they used to call AAC(3)-II (9), a name still in use by other authors (4, (12) (13) (14) . Regrettably, this has not been mentioned by the authors. In our experience, the use of two names for a single protein is very confusing for those who are not dealing with this matter on a daily basis.
For your information, and in an attempt to shed some light on this matter, we present some historical data. In 1974, Le Goffic et al. (8) reported the isolation of an R factor from a clinical isolate of Kiebsiella (R-176) that coded for a 3-Nacetyltransferase causing resistance to gentamicin, tobramycin, and kanamycin. Since this was the second enzyme exhibiting 3-N-acetyltransferase activity and since it differed physically from the first (5), the authors proposed the name AAC(3)-II. After these two enzymes were discovered, AAC(3)-III, a Pseudomonas-specific enzyme, was found in 1976 (3) and AAC(3)-IV was found in 1978 (6) .
In 1980, Gomez-Lus et al. (7) described the isolation of a 3-N-acetyltransferase that, in their opinion, differed from the other four. However, they did not purify the enzyme, and basically the substrate profile of the novel enzyme resembled that of AAC (3) (5) which has a substrate specificity resembling those of two previously described 3-N-acetyltransferases, the AAC(3)-II enzyme described by LeGoffic et al. (4) and the AAC(3)-V enzyme described by Gomez-Lus et al. (3) . The AAC(3)-V profile was defined again by Shimizu et al. (7) and used by Barg (2) , who developed a DNA probe for the gene encoding this enzyme from plasmid pC190. Shimizu et al. (7) switched from the AAC(3)-II to the AAC(3)-V nomenclature on the basis of slight differences in the resistance profiles reported by Gomez-Lus et al. (3) . In retrospect, this may have been in error, since the enzymes encoding the resistance profiles AAC(3)-II and AAC(3)-V are likely to be identical.
The AAC(3)-V probe developed by Barg (2) hybridized with a strain containing the plasmid pWP113a, which had been incorrectly described in Allmansberger et al. (1) as encoding an AAC(3)-III enzyme. In fact, the plasmid from which this AAC(3)-V probe was obtained was highly similar to pWP113a. Therefore, on the basis of this study, it seemed appropriate that an AAC(3)-V enzyme was encoded by pWP113a. Interestingly, the AAC(3)-V probe did not hybridize with a strain obtained from Bristol, producing an AAC(3)-II enzyme (2) . In retrospect, it is likely that this AAC(3)-II strain may carry the same gene described by us (5) or a third isoenzyme.
The DNA sequence of another 3'-N-acetyltransferase was subsequently determined by Vliegenthart et al. (8) . Even though this gene had complete homology to the gene on pWP113a, already described as encoding an AAC(3)-V enzyme (2), it was described as encoding an AAC(3)-II enzyme.
At Schering-Plough Research Institute, the AAC(3)-Va probe obtained from pC190 (2) 
